AstraZeneca's potential COPD treatment improved lung function in patients during two Phase III clinical trials.
Wilmington - Home, The News Journal
Fri, 03/20/2015 - 5:22am
AstraZeneca's potential COPD treatment improved lung function in patients during two Phase III clinical trials.